Inventor

Schäfer Martina

DE26 patents

⚠️ This page may combine multiple inventors who share the name “Schäfer Martina”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

Schäfer Martina

Bayer Pharma AG

Bicyclically substituted uracils and the use thereof

Bicyclically substituted uracils and the use thereof

Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments

Substituted oxopyridine derivatives and use thereof cardiovascular disorders

Bicyclically substituted uracils and the use thereof

Bicyclically substituted uracils and the use thereof

Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders

Substituted oxopyridine derivatives and use thereof as factor xia/plasma

Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders

Antibodies capable of binding to the coagulation factor XIa and uses thereof

Antibodies capable of binding to the coagulation Factor XI and/or its activated form factor Xia and uses thereof

Substituted uracils and use thereof

Substituted oxopyridine derivatives and use thereof as factor XIa/plasma

Substituted oxopyridine derivatives

Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives

Substituted oxopyridine derivatives

Nucleic acids and host cells expressing antibodies capable of binding to the coagulation factor XIa and uses thereof

Antibodies capable of binding to the coagulation factor XIa and uses thereof

BAYER AG

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

4,5-annulated 1,2,4-triazolones

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

4,5-annulated 1,2,4-triazolones

Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof

Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitors